Advances in Medical Management of Early Stage and Advanced Breast Cancer: 2015.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 26617211.
- Also identified by DOI 10.1016/j.semradonc.2015.09.005.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Standard management of early stage and advanced breast cancer has been improved over the past few years by knowledge gained about the biology of the disease, results from a number of eagerly anticipated clinical trials and the development of novel agents that offer our patients options for improved outcomes or reduced toxicity or both. This review highlights recent major developments affecting the systemic therapy of breast cancer, broken down by clinically relevant patient subgroups and disease stage, and briefly discusses some of the ongoing controversies in the treatment of breast cancer and promising therapies on the horizon.
Medical subject headings
- Antineoplastic Agents
- Breast Neoplasms